Published: 25 September 2020
Author(s): Giuseppe Patti, Marco Mennuni, Francesco Della Corte, Enrico Spinoni, Pier Paolo Sainaghi, for the COVID-UPO Clinical Team
Section: Letter to the Editor

After the first autochthonous case described on February 19, also in Italy the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection rapidly circulated, mainly in the Northern regions of the country. The earliest reports on Coronavirus disease-19 (COVID-19) have described worldwide a high prevalence of severe respiratory illness [1]. A suggestive feature of COVID-19 has been a rapid progression of the respiratory impairment, leading to acute respiratory distress syndrome (ARDS) and often requiring ventilation support [2].

Newsletters

Stay informed on our latest news!